Skip to main content
Premium Trial:

Request an Annual Quote

Covance to Collaborate with Broad Institute on microRNA Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Covance today said that it will collaborate with the Broad Institute on microRNA expression research on an unidentified research model.

Princeton, NJ-based Covance said that the collaboration will utilize its next-generation sequencing capabilities to profile microRNA expression in various tissue samples from the model, which the firm said has proven valuable for understanding various human diseases including respiratory, oncology, and cardiovascular diseases.

"In collaborating with the Broad Institute on this project, our shared hope is that parallel characterization of microRNA expression will contribute to our understanding of the underlying transcriptional regulatory networks," said Tom Turi, VP of Science and Technology for Covance Discovery and Translational Services. "These studies will rapidly expand our current knowledge of this area, laying the ground work for in-depth investigation of biomedically-relevant disease processes."

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.